Lista de obras -

Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders

scientific article published on 01 September 2019

Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?

artículo científico publicado en 2013

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis

artículo científico publicado en 2019

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.

artículo científico publicado en 2017

Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center

artículo científico publicado en 2019

Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment

scientific article published on 23 September 2020

Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum.

artículo científico publicado en 2016

Commensal Clostridia: leading players in the maintenance of gut homeostasis.

artículo científico

Commentary to "Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease"

scientific article published on 01 July 2019

Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel

artículo científico publicado en 2018

Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of action.

artículo científico publicado en 2015

Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis

artículo científico publicado en 2016

Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis.

artículo científico publicado en 2017

Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD?

artículo científico publicado en 2014

Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders?

artículo científico publicado en 2017

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease.

artículo científico publicado en 2016

Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility

artículo científico publicado en 2013

Gut microbiota and inflammatory bowel disease: an update.

artículo científico publicado en 2017

Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease.

artículo científico publicado en 2018

IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair

article published in the Proceedings of the National Academy of Sciences of the United States of America

Impact of the Trophic Effects of the Secretome From a Multistrain Probiotic Preparation on the Intestinal Epithelia

scientific article published on 10 December 2020

Infliximab does not increase colonic cancer risk associated to murine chronic colitis.

artículo científico publicado en 2016

Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities

scientific article published on 01 January 2019

Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice.

artículo científico publicado en 2013

New C-23 modified of silybin and 2,3-dehydrosilybin: synthesis and preliminary evaluation of antioxidant properties.

artículo científico publicado en 2011

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide.

scientific article published on 03 January 2017

Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives.

artículo científico

Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update

artículo científico publicado en 2016

Skeletal muscle-gut axis: emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases

scientific article published on 18 July 2018

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.

artículo científico publicado en 2017

The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin.

artículo científico publicado en 2016

The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications

artículo científico publicado en 2020

ToF-SIMS and principal component analysis of lipids and amino acids from inflamed and dysplastic human colonic mucosa

artículo científico publicado en 2017

Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila

artículo científico publicado en 2020

[Microbiota and inflammatory bowel disease: an update.]

scientific article published on 01 December 2018

Lista de obras de

Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders

Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.

Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center

Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment

Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum.

Commensal Clostridia: leading players in the maintenance of gut homeostasis.

Commentary to "Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease"

Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel

Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of action.

Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis

Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis.

Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD?

Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders?

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease.

Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility

Gut microbiota and inflammatory bowel disease: an update.

Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease.

IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair

Impact of the Trophic Effects of the Secretome From a Multistrain Probiotic Preparation on the Intestinal Epithelia

Infliximab does not increase colonic cancer risk associated to murine chronic colitis.

Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities

Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice.

New C-23 modified of silybin and 2,3-dehydrosilybin: synthesis and preliminary evaluation of antioxidant properties.

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide.

Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives.

Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update

Skeletal muscle-gut axis: emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.

The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin.

The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications

ToF-SIMS and principal component analysis of lipids and amino acids from inflamed and dysplastic human colonic mucosa

Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila

[Microbiota and inflammatory bowel disease: an update.]